DT388GMCSF Fusion Protein

DT388 GM-CSF fusion protein · MD Anderson Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DT388GMCSF Fusion Protein, covering 2012-02-22 to 2012-02-22. Get the full timeline:

Most recent: Clinical Trial Update: Study of DT388GMCSF Fusion Protein in Acute Myelogenous Leukemia (AML) and Chronic Myelomonocytic Leukemia (CMML) [Phase 1]

See pricing